CME credit for this article is now expired. It appears here for informational purposes only. Some of the material may have changed.
Premiere Date: November 20, 2013
Expiration Date: November 20, 2014
This article provides an overview of the changes in DSM-5 and a review of how DSM-5 relates to ICD-10-CM.
At the end of this article, readers should be able to:
1. Describe the relationship of DSM-5 and ICD-10-CM.
2. Recognize how DSM-5 can translate into changes in clinical practice.
3. Analyze how changes occurring in mental health might impact mental health records, regulatory policies, and reimbursement models.
This continuing medical education activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders.
CME Credit (Physicians): This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of CME Outfitters, LLC, and Psychiatric Times. CME Outfitters, LLC, is accredited by the ACCME to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Nurse Practitioners and Physician Assistants: AANPCP and AAPA accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer-review process.
The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Ihsan Salloum, MD, MPH, reports that he receives grant support from the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
Ingrid Vasiliu-Feltes, MD, MBA, has no disclosures to report.
Lloyd I. Sederer, MD (peer/content reviewer), reports that he receives grant support from the National Institute of Mental Health and the National Center for Complementary and Alternative Medicine.
Applicable Psychiatric Times staff have no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, and the faculty do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
Dr Salloum is Chief of the Division of Substance and Alcohol Abuse in the Department of Psychiatry and Behavioral Sciences at the University of Miami, Miller School of Medicine, Miami. Dr Vasiliu-Feltes is Chief of Clinical Compliance and Quality Assurance and Director of the Clinical Trials Program in the Department of Psychiatry and Behavioral Sciences at the University of Miami, Miller School of Medicine.
1. López-Muñoz F, García-García P, Sáiz-Ruiz J, et al. A bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 years. Psychopathology. 2008;41:214-225.
2. Mezzich JE. International surveys on the use of ICD-10 and related diagnostic systems. Psychopathology. 2002;35:72-75.
3. Kramer M. Historical roots and structural bases of the International Classification of Diseases. In: Mezzich JE, von Cranach M, eds. International Classification in Psychiatry: Unity and Diversity. Cambridge, UK: Cambridge University Press; 1988.
4. Feighner JP, Robins E, Guze SB, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972;26:57-63.
5. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Psychopharmacol Bull. 1975;11:22-25.
6. The White House. Health reform. 2013. http://www.whitehouse.gov/healthreform. Accessed October 9, 2013.
7. US Department of Health and Human Services. http://www.hhs.gov. Accessed October 9, 2013.
8. North Carolina Healthcare Information & Communications Alliance, Inc. http://www.nchica.org. Accessed October 9, 2013.
9. Substance Abuse and Mental Health Services Administration. http://www.samhsa.gov. Accessed October 9, 2013.
10. Centers for Medicare and Medicaid Services. http://www.cms.gov. Accessed October 9, 2013.
11. Mises R, Quemada N, Botbol M, et al. French classification for child and adolescent mental disorders. Psychopathology. 2002;35:176-180.
12. Otero-Ojeda AA. Third Cuban Glossary of Psychiatry (GC-3): key features and contributions. Psychopathology. 2002;35:181-184.
13. Chen YF. Chinese classification of mental disorders (CCMD-3): towards integration in international classification. Psychopathology. 2002;35:171-175.
14. Lee S. From diversity to unity. The classification of mental disorders in 21st-century China. Psychiatr Clin North Am. 2001;24:421-431.
15. Berganza CE, Mezzich JE, Jorge MR. Latin American Guide for Psychiatric Diagnosis (GLDP). Psychopathology. 2002;35:185-190.
16. Berganza CE, Mezzich JE, Otero-Ojeda AA, et al. The Latin American guide for psychiatric diagnosis. A cultural overview. Psychiatr Clin North Am. 2001;24:433-446.
17. Saavedra JE, Mezzich JE, Otero A, Salloum IM. The revision of the Latin American Guide for Psychiatric Diagnosis (GLADP) and an initial survey on its utility and prospects. Int J Pers Cent Med. 2012;2:214-221.
18. Saavedra JE, Otero A, Salloum IM, Mezzich JE. The revision of the Latin American Guide for Psychiatric Diagnosis (GLADP): a person centered approach to international classification. Int J Pers Cent Med. 2011;1:446-455.
19. Mezzich JE. The WPA International Guidelines for Diagnostic Assessment. World Psychiatry. 2002;1:36-39.
20. Salloum IM, Mezzich JE. Person-centered diagnosis. Int J Integr Care. 2010;10(suppl):e027.
21. Mezzich JE, Salloum IM, Cloninger CR, et al. Person-centred integrative diagnosis: conceptual bases and structural model. Can J Psychiatry. 2010;55:701-708.